as of the last version of complaint i saw thomas is asking
as of the last version of complaint i saw thomas is asking NNLX to recreate financials back to 2014?
if NNLX could not afford to present financials in otc format back then they certainly cannot afford to hire a specialized forensic accountant to recreate them now
he wants a shareholders meeting so he can take control of NNLX at such meeting
he bought stock after the damage was already done so perhaps in the range of .001 to .00001 - you can accumulate a lot of stock at that price very cheaply
you dont have to have a majority of the stock to win shareholder meetings.
if nobody else has a larger block of stock you can win on as low as perhaps 1/3 of the stock
does Bret have a poison pill- a construction to keep a hold of the company in case of a hostile take over- I dont remember our previous discussion on that
he listed probably anywhere from 70 - 99 items.
he wants the court case if he can get standing in New Jersey where he reportedly lives.
a lot of companies choose to register in corporate friendly states for various reasons
Such registration usually has very limited value in determining jurisdiction.
Jurisdiction usually is where the corporation is actually physically located-which was Hubbard Ohio
In violation of the general rules of jurisdiction he wants case in NJ
He is not the first to argue that fax machines etc make it unnecessary to follow general rules. In all cases I've been aware of the judge has denied such arguments.
He wants a direct action instead of a stockholder class action bc a direct action doesn't just put him at the head of the class it puts him above the class - he wants to become as noted the new chairman w apparent ownership of 60% of the stock -a greater % than ceo Bret
he wants the patents to be decisively ruled as property of NNLX which he is trying to take over
in 2004 there was a lawsuit between the previous company - before Bret et al -part of the problem there was the valuation of the patents
its hard to value patents beyond a cost basis
if thomas has some kind of private agreement w some medical company to use one or more of the many patents that would increase the value of said patents
thomas hasnt revealed any such for he wants to get NNLX as cheaply as possible
thomas wants standing. he has admitted to buying the stock after all the damage from NNLX's violations occurred
so he wants to be made whole for things he knew going in-and not just that- he wants to be elected Ceo and chairman etc w 60% of the stock
and that is just what can be determined at the present time
is this a one time thing? hedge funds patrol low pennies to short them into oblivion,violating normal rules of shorting
real estate investors take advantage of homeowners financial troubles offering generally anywhere from 10 to 70 cents on the dollar
since covid those who deal regularly w scams say scams have multiplied astronomically
many here will now say NNLX was a scam. It wasnt - there are a lot of easier ways to scam than painfully nurse such a company reportedly without salary or compensation from stock. Most if not all officers and directors reportedly having other paying jobs except for maybe ceo bret.
just presenting facts- so keep your eyes open, though its apparent some are not
Over 90% of low penny startups fail. Many such low penny startups violate different forms of fiduciary duty. That does NOT make it right but how can so many usually blame the company as if the company was personally out to get them
the biggest violation was not getting back to us after the big PR re 3 major things Brets superlawyer brother (apparently has 2 other lawyer brothers bart and daniel) and NNLX were going to do to get current with otc etc
Does somebody have easy access to that PR who can post it so we can be reminded?
You know when thomas actually files the complaint NNLX will probably have 20 days to put in an appearance.
the judge's first decison is probably, does thomas have standing as part a direct - not class action shareholder- suit.
or actually could first deny the attempt to give new jersey jurisdiction
in which case thomas would probably file in ohio- where the normal obvious jurisdiction would be
those are the first points NNLX would argue in their response
only after standing and venue are determined would any discovery-interrogatories and depositions- begin-which can take a long time.
that situation makes it harder for thomas to get standing whereas a class action stockholder suit would have much easier time achieving standing for many many stockholders have had material losses
1
1
Nanologix Inc (NNLX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Modular Solutions Steal the Show in Bangkok When a company draws 59,468 attendees from over 150 countries, folks pay attention—and that was exactly the scene at Gastech 2026 in Bangkok. The name buzzing on many lips? Endurance Energy. These guys showcased a fresh take on energy logistics with their skid-mounted liquefaction tech, turning heads with their Southeast Asia...
Continue Reading
Shining a Light on Essential Family Farmers Every year, thousands gather for Farm Aid to back the unsung heroes who put food on our plates. In 2026, the scene shifted to the amphitheater at Virginia Beach, where an epic lineup of music took stage not just to entertain but to underline a critical issue—family farmers are fighting for survival. These folks aren't merely...
Continue Reading
What's Going On with AST SpaceMobile? Kicking off with a heavy hitter here, folks. AST SpaceMobile, Inc., trading under NASDAQ:ASTS, is under a securities fraud spotlight. We're talking allegations piled higher than a morning stack of pancakes. If you picked up any ASTS shares between March 4, 2025, and July 15, 2026, you're in on this rough ride. There's a class action...
Continue Reading
Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...
Continue Reading
An Unpredicted Victory in Samarkand Well, color me surprised. Timur Turlov's made waves by clinching the role of FIDE President at the General Assembly in Samarkand. This one's quite the turn for the chess world—Kazakhstan’s own stepping up to run the whole show. This isn't just some ceremonial post either. Turlov, who's been pulling strings over at the Kazakhstan...
Continue Reading
Unseen Perils of Winter Heating in Massachusetts Massachusetts homeowners, listen up. If your heating system is older than the Model T, it's time to rethink your winter strategy. You don't want to be stuck in the cold when the thermometer hits single digits, do you? That's where Townsend comes in, making waves with their rebate assistance program. Navigating the Rebate...
Continue Reading
Taking Flight with Legacy and Tradition Throwing a bash on Times Square isn't just about flash; it's about letting folks know you mean business. And China Southern Airlines has been doing just that for 70 years. Imagine starting from Guangzhou and ending up splashed across New York City's giant LED screens—talk about a journey! From Humble Roots to Global Network...
Continue Reading
Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...
Continue Reading
IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...
Continue Reading
Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...
Continue Reading
Top 5 Most Recently Viewed Articles
Nxera Pharma Secures Milestone Payments After Major Development Tokyo and Cambridge have become focal points for significant advancements in pharmaceutical research and development thanks to innovative companies such as Nxera Pharma Co., Ltd. Recently, Nxera has made headlines by announcing the receipt of US$4.8 million in milestone payments from Centessa Pharmaceuticals...
Continue Reading
Douglas Elliman Inc. Announces Major Leadership Change Douglas Elliman Inc. (NYSE: DOUG), a prominent name in the real estate sector, has recently made headlines with its significant leadership transition. Howard M. Lorber, who has admirably held the roles of President, Chief Executive Officer, and Chairman of the Board, has decided to retire. His retirement is marked by...
Continue Reading
Diving into Marine Audio with Rockford Fosgate In the tumultuous sea of audio solutions, the newest splash comes from Rockford Fosgate with their PMX-6BB Hidden Digital Media Receiver. Now for a gearhead, this isn’t just about bass and beats; it's about transforming any boat into a high-fidelity audio haven. Designed specifically for marine environments, this device is...
Continue Reading
Manley Creative Unveils Its New Brand Identity In a dynamic shift for the agency, Manley Creative has chosen to refresh its brand, marking a significant milestone in its evolution. Established by Jim Manley in 2005, this full-service agency has grown from a solo venture into a thriving enterprise that specializes in video production and digital marketing. The rebrand...
Continue Reading
Smurfit Westrock Approves Significant Quarterly Dividend Smurfit Westrock plc (NYSE:SW, LSE:SWR) has just announced an exciting development that will impact its shareholders significantly. The company's Board has approved a quarterly dividend of $0.4308 for each share of its ordinary shares. This dividend is a testament to Smurfit Westrock's commitment to rewarding its...
Continue Reading